Your search returned 25 results.

Results
	1.	New and improved glucocorticoid receptor ligands. [electronic resource] by Miner, Jeffrey N Hong, Mei Hua Negro-Vilar, Andrés Producer: 20060612 In: Expert opinion on investigational drugs vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification. [electronic resource] by Tooker, Patricia Yen, Wan-Ching Ng, Shi-Chung Negro-Vilar, Andrès Hermann, Thomas W Producer: 20070618 In: Cancer research vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): findings from a pilot study. [electronic resource] by Rosenthal, Murray Moore, Polly Groves, Eric Iwan, Tad Schlosser, Lisa Greenberg Dziewanowska, Zofia Negro-Vilar, Andres Producer: 20080103 In: Journal of opioid management vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma. [electronic resource] by Prince, H Miles Duvic, Madeleine Martin, Ann Sterry, Wolfram Assaf, Chalid Sun, Yijun Straus, David Acosta, Mark Negro-Vilar, Andres Producer: 20100429 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A selective retinoid X receptor agonist bexarotene (Targretin) prevents and overcomes acquired paclitaxel (Taxol) resistance in human non-small cell lung cancer. [electronic resource] by Yen, Wan-Ching Corpuz, Manny R Prudente, Rene Y Cooke, Tracy A Bissonnette, Reid P Negro-Vilar, Andrés Lamph, William W Producer: 20050930 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells. [electronic resource] by Hermann, Thomas W Yen, Wan-Ching Tooker, Patricia Fan, Bingqi Roegner, Karen Negro-Vilar, Andrés Lamph, William W Bissonnette, Reid P Producer: 20051223 In: Lung cancer (Amsterdam, Netherlands) vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator. [electronic resource] by van Oeveren, Arjan Motamedi, Mehrnouch Mani, Neelakandha S Marschke, Keith B López, Francisco J Schrader, William T Negro-Vilar, Andrés Zhi, Lin Producer: 20061204 In: Journal of medicinal chemistry vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: improved physical functioning in the ACTION trial. [electronic resource] by Rauck, Richard L Bookbinder, Stephen A Bunker, Timothy R Alftine, Christopher D Gershon, Steven de Jong, Egbert Negro-Vilar, Andres Ghalie, Richard Producer: 20070404 In: Journal of opioid management vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. [electronic resource] by Rauck, Richard L Bookbinder, Stephen A Bunker, Timothy R Alftine, Christopher D Ghalie, Richard Negro-Vilar, Andres de Jong, Egbert Gershon, Steven Producer: 20070405 In: Journal of opioid management vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. [electronic resource] by Rauck, Richard L Bookbinder, Stephen A Bunker, Timothy R Alftine, Christopher D Ghalie, Richard Negro-Vilar, Andres de Jong, Egbert Gershon, Steven Producer: 20070314 In: Journal of opioid management vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Peptide binding identifies an ERalpha conformation that generates selective activity in multiple in vitro assays. [electronic resource] by Larson, Christopher J Osburn, Deborah L Schmitz, Katherine Giampa, Leslie Mong, Shau-Ming Marschke, Keith Seidel, H Martin Rosen, Jonathan Negro-Vilar, Andrés Producer: 20051123 In: Journal of biomolecular screening vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Cell-specific activation of the human skeletal alpha-actin by androgens. [electronic resource] by Hong, Mei Hua Sun, Hong Jin, Cheng He Chapman, Mark Hu, Junlian Chang, William Burnett, Kelven Rosen, Jon Negro-Vilar, Andres Miner, Jeffrey N Producer: 20080422 In: Endocrinology vol. 149 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones. [electronic resource] by van Oeveren, Arjan Pio, Barbara A Tegley, Christopher M Higuchi, Robert I Wu, Min Jones, Todd K Marschke, Keith B Negro-Vilar, Andrés Zhi, Lin Producer: 20070529 In: Bioorganic & medicinal chemistry letters vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile. [electronic resource] by Miner, Jeffrey N Ardecky, Bob Benbatoul, Khalid Griffiths, Kimberly Larson, Christopher J Mais, Dale E Marschke, Keith Rosen, Jon Vajda, Eric Zhi, Lin Negro-Vilar, Andres Producer: 20080118 In: Proceedings of the National Academy of Sciences of the United States of America vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones. [electronic resource] by van Oeveren, Arjan Motamedi, Mehrnoush Martinborough, Esther Zhao, Shuo Shen, Yixing West, Sarah Chang, William Kallel, Adam Marschke, Keith B López, Francisco J Negro-Vilar, Andrés Zhi, Lin Producer: 20070529 In: Bioorganic & medicinal chemistry letters vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer. [electronic resource] by Dragnev, Konstantin H Petty, W Jeffrey Shah, Sumit J Lewis, Lionel D Black, Candice C Memoli, Vincent Nugent, William C Hermann, Thomas Negro-Vilar, Andres Rigas, James R Dmitrovsky, Ethan Producer: 20070613 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II. [electronic resource] by Blumenschein, George R Khuri, Fadlo R von Pawel, Joachim Gatzemeier, Ulrich Miller, Wilson H Jotte, Robert M Le Treut, Jacques Sun, Show-Li Zhang, Jinkun K Dziewanowska, Zofia E Negro-Vilar, Andres Producer: 20080505 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I. [electronic resource] by Ramlau, Rodryg Zatloukal, Petr Jassem, Jacek Schwarzenberger, Paul Orlov, Sergei V Gottfried, Maya Pereira, Jose Rodrigues Temperley, Guillermo Negro-Vilar, Rosa Rahal, Samia Zhang, Joseph K Negro-Vilar, Andres Dziewanowska, Zofia E Producer: 20080505 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Identification of polymorphisms associated with hypertriglyceridemia and prolonged survival induced by bexarotene in treating non-small cell lung cancer. [electronic resource] by Luo, Wen Schork, Nicholas J Marschke, Keith B Ng, Shi-Chung Hermann, Thomas W Zhang, Jinkun Sanders, Jennifer M Tooker, Patricia Malo, Nathalie Zapala, Matthew A Dziewanowska, Zofia E Negro-Vilar, Andres Meglasson, Martin D Producer: 20111019 In: Anticancer research vol. 31 Availability: No items available. Save to lists Add to cart (remove)
	20.	An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. [electronic resource] by Miner, Jeffrey N Chang, William Chapman, Mark S Finn, Patricia D Hong, Mei Hua López, Francisco J Marschke, Keith B Rosen, Jon Schrader, William Turner, Russell van Oeveren, Arjan Viveros, Humberto Zhi, Lin Negro-Vilar, Andres Producer: 20070213 In: Endocrinology vol. 148 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 25 results.